Denise Abbel

After obtaining my medical bachelor’s degree in 2021, I finished the master’s Vitality and Ageing at the Leiden University and the master’s Health Care Management at the Erasmus University in Rotterdam both in 2022. In January 2023, I started my PhD trajectory at the department of Gerontology and Geriatrics at the Leiden University Medical Centre (LUMC). As part of SERENITY, I am focusing on antithrombotic therapy in cancer patients with limited life expectancy. Since antithrombotic therapies provide delayed benefits and immediate risks, the question remains if prescribing antithrombic drugs is appropriate for cancer patients with limited life expectancy. My previous research mainly focused on dementia and end of life decisions in the elderly.

Follow me on LinkedIn